Tolerability of Antiseizure Medications in Individuals With Newly Diagnosed Epilepsy

In this 30-year longitudinal cohort study of 1795 patients with newly diagnosed and treated epilepsy at a specialist clinic in Glasgow, the intolerable adverse effect rate observed was not improved despite the increased using of second-generations antiseizure medications.


JAMA Neurology